Form4insider filings, from the source

Company · CIK 0001070081 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

PTC THERAPEUTICS, INC. · PTCT

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $22.5M · 17net −$22.5M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesMar 28Apr 27May 28Jun 28Jul 29Aug 28Sep 28

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 16, 2026 SForm 4 →Sep 18, 5:20 pm EDTMichael SchmertzlerDirector20,000$67.49$1,349,7281,296,594−1.52%10b5-1
Sep 9, 2026 SForm 4 →Sep 11, 5:20 pm EDTMichael SchmertzlerDirector20,000$67.59$1,351,8031,316,594−1.50%10b5-1
Aug 26, 2026 SForm 4 →Aug 28, 5:20 pm EDTMichael SchmertzlerDirector25,000$72.26$1,806,5091,336,594−1.84%10b5-1
Aug 19, 2026 SForm 4 →Aug 21, 5:20 pm EDTMichael SchmertzlerDirector25,000$72.22$1,805,4111,361,594−1.80%10b5-1
Aug 17, 2026 SForm 4 →Aug 19, 5:20 pm EDTMark Elliott BouldingEXEC. VP AND CLO2,813$72.57$204,127105,272−2.60%10b5-1
Aug 17, 2026 MForm 4 →Aug 19, 5:20 pm EDTMark Elliott BouldingEXEC. VP AND CLO2,813$25.69$72,266108,085—10b5-1
Aug 4, 2026 SForm 4 →Aug 6, 5:20 pm EDTMatthew B. KleinCHIEF EXECUTIVE OFFICER, Director10,292$68.57$705,722383,868−2.61%10b5-1
Jul 28, 2026 AForm 4 →Jul 30, 9:02 pm EDTHege Elisabeth Sollie-ZetlmayerDirector6,000——52,526—
Jul 14, 2026 SForm 4 →Jul 16, 5:20 pm EDTPierre GravierCHIEF FINANCIAL OFFICER3,494$80.35$280,74383,986−3.99%10b5-1
Jul 9, 2026 SForm 4 →Jul 13, 5:20 pm EDTMary L. SmithDirector15,834$90.00$1,425,06021,813−42.1%10b5-1
Jul 9, 2026 MForm 4 →Jul 13, 5:20 pm EDTMary L. SmithDirector15,834$42.95$680,07027,647—10b5-1
Jul 9, 2026 SForm 4 →Jul 13, 5:20 pm EDTNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER2,464$90.25$222,37660,299−3.93%10b5-1
Jul 9, 2026 MForm 4 →Jul 13, 5:20 pm EDTNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER2,464$46.54$114,67562,763—10b5-1
Jul 6, 2026 SForm 4 →Jul 8, 5:20 pm EDTMark Elliott BouldingEXEC. VP AND CLO5,079$85.08$432,118105,272−4.60%10b5-1
Jul 6, 2026 MForm 4 →Jul 8, 5:20 pm EDTMark Elliott BouldingEXEC. VP AND CLO5,079$43.36$220,243108,085—10b5-1
Jul 6, 2026 SForm 4 →Jul 8, 5:20 pm EDTNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER46,774$87.52$4,093,48260,299−43.7%10b5-1
Jul 6, 2026 MForm 4 →Jul 8, 5:20 pm EDTNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER46,774$38.86$1,817,84484,912—10b5-1
Jun 26, 2026 SForm 4 →Jun 30, 5:20 pm EDTNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER8,130$85.26$693,15160,137−11.9%10b5-1
Jun 26, 2026 MForm 4 →Jun 30, 5:20 pm EDTNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER8,130$38.10$309,75367,855—10b5-1
Jun 24, 2026 SForm 4 →Jun 26, 5:20 pm EDTNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER26,283$85.78$2,254,46360,137−30.4%10b5-1
Jun 24, 2026 MForm 4 →Jun 26, 5:20 pm EDTNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER26,283$38.11$1,001,51460,237—10b5-1
Jun 22, 2026 SForm 4 →Jun 24, 5:20 pm EDTNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER23,749$80.90$1,921,37860,137−28.3%10b5-1
Jun 22, 2026 MForm 4 →Jun 24, 5:20 pm EDTNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER23,749$25.69$610,11283,886—10b5-1
Jun 17, 2026 SForm 4 →Jun 22, 5:20 pm EDTChristine Marie UtterSVP, CHIEF ACCOUNTING OFFICER19,686$75.56$1,487,47470,199−21.9%10b5-1
Jun 17, 2026 MForm 4 →Jun 22, 5:20 pm EDTChristine Marie UtterSVP, CHIEF ACCOUNTING OFFICER19,686$25.69$505,73389,885—10b5-1
Jun 17, 2026 SForm 4 →Jun 22, 5:20 pm EDTMark Elliott BouldingEXEC. VP AND CLO10,462$78.65$822,868105,272−9.04%10b5-1
Jun 17, 2026 MForm 4 →Jun 22, 5:20 pm EDTMark Elliott BouldingEXEC. VP AND CLO10,522$46.54$489,694107,284—10b5-1
Jun 10, 2026 MForm 4 →Jun 12, 5:30 pm EDTEric PauwelsCHIEF BUSINESS OFFICER17,566$18.01$316,36490,977—10b5-1
Jun 10, 2026 SForm 4 →Jun 12, 5:30 pm EDTEric PauwelsCHIEF BUSINESS OFFICER21,277$75.00$1,595,77573,411−22.5%10b5-1

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 17, 2026 MForm 4 →Aug 19, 5:20 pm EDTMark Elliott BouldingEXEC. VP AND CLO2,813——16,876—10b5-1
Jul 28, 2026 AForm 4 →Jul 30, 9:02 pm EDTHege Elisabeth Sollie-ZetlmayerDirector5,213——1,738—
Jul 9, 2026 MForm 4 →Jul 13, 5:20 pm EDTMary L. SmithDirector15,834——0—10b5-1
Jul 9, 2026 MForm 4 →Jul 13, 5:20 pm EDTNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER2,464——45,036—10b5-1
Jul 6, 2026 MForm 4 →Jul 8, 5:20 pm EDTMark Elliott BouldingEXEC. VP AND CLO5,039——28,125—10b5-1
Jul 6, 2026 MForm 4 →Jul 8, 5:20 pm EDTNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER46,774——9,063—10b5-1
Jun 26, 2026 MForm 4 →Jun 30, 5:20 pm EDTNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER8,130——19,687—10b5-1
Jun 24, 2026 MForm 4 →Jun 26, 5:20 pm EDTNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER26,283——36,150—10b5-1
Jun 22, 2026 MForm 4 →Jun 24, 5:20 pm EDTNeil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER23,749——23,751—10b5-1
Jun 17, 2026 MForm 4 →Jun 22, 5:20 pm EDTChristine Marie UtterSVP, CHIEF ACCOUNTING OFFICER19,686——15,314—10b5-1
Jun 17, 2026 MForm 4 →Jun 22, 5:20 pm EDTMark Elliott BouldingEXEC. VP AND CLO10,522——30,938—10b5-1
Jun 10, 2026 SForm 4 →Jun 12, 5:30 pm EDTEric PauwelsCHIEF BUSINESS OFFICER17,566——0—10b5-1